Menu
Enrolling by invitation NCT07594496

Prevalence and Clinical Manifestations of Cannabis Withdrawal in Hospitalized Patients With Hematological Malignancies Undergoing Bone Marrow Transplant (BMT) or Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

— Observational Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study evaluates the prevalence of cannabis withdrawal and the clinical manifestations of cannabis withdrawal syndrome in patients hospitalized for BMT or CAR-T therapy.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Prevalence of cannabis withdrawal [Time frame: Up to 1 year]
  • Severity of withdrawal symptoms [Time frame: Daily for first 4 days of hospitalization]
Secondary outcome measures (1)
  • Mortality Rate [Time frame: Up to 1 year]

Eligibility criteria

Inclusion criteria

  • All adult patients admitted for BMT or CAR-T therapy

Exclusion criteria

  • Individuals unable to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Mayo Clinic in Arizona — Scottsdale

Identifiers

NCT: NCT07594496 · 25-011419

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗